Ascentage Pharma Group International (AAPG) stock
AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.01−0.13 (-0.97%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Ascentage Pharma Group International price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ascentage Pharma Group International's price to sales ratio was 16.3× on Nov 11, 2026, against 18.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 16.3× | +1.5 |
| 2025 | Dec 31, 2025 | 14.7× | – |
See a number that looks wrong?